Rapid Micro Biosystems, Inc. (RPID)
$0.87-1.14%Close
SELLCRISIS · day 47
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $39M
- Beta
- 1.50
- P/E (TTM)
- -0.79
- Short % float
- 3.23%
- Days to cover
- 2.3
- SI change
- -9.2%
- 1W
- -7.45%
- 1M
- -25.64%
- vs SPY 1W
- -7.31%
- vs SPY 1M
- -28.15%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 6
- GROWTH
- 25
- GARP
- 1
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-106.2%
REV YoY-
ROE-177.0%
EPS YoY-
ROA-87.6%
GROSS10
OP-141
NET-146
[VALUATION]
P/E TTM-0.79
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B2.31
P/FCF-
EV/EBITDA-1.06
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E132.29
ALTMAN Z-
CURR RATIO2.55
ND/EBITDA-
BETA1.50
Company news
FAQ
- What is LOPJLB’s current signal on RPID?
- LOPJLB’s latest quantitative signal on Rapid Micro Biosystems, Inc. (RPID) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RPID in?
- Rapid Micro Biosystems, Inc. (RPID) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Rapid Micro Biosystems, Inc. (RPID) do?
- Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specia…